Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 514719, 12 pages
http://dx.doi.org/10.1155/2013/514719
Research Article

Aqueous Extract of Solanum nigrum Leaves Induces Autophagy and Enhances Cytotoxicity of Cisplatin, Doxorubicin, Docetaxel, and 5-Fluorouracil in Human Colorectal Carcinoma Cells

1Department of Chinese Medicine, Taipei Medical University Hospital, Taipei 11031, Taiwan
2Department of Obstetrics and Gynecology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan
3Division of Hematology and Oncology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei 11031, Taiwan
4Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan
5Division of General Surgery, Department of Surgery, Chi Mei Hospital Chiali, Tainan 72263, Taiwan
6Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan
7Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan
8Department of Surgery, Taipei Medical University and Hospital, Taipei 11031, Taiwan
9Division of General Surgery, Department of Surgery, Taipei Medical University Hospital, Taipei Medical University, Taipei 11031, Taiwan
10Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei 11031, Taiwan

Received 14 March 2013; Revised 15 May 2013; Accepted 22 May 2013

Academic Editor: Jing Hua Wang

Copyright © 2013 Chen-Jei Tai et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. P. Coleman, M. Quaresma, F. Berrino et al., “Cancer survival in five continents: a worldwide population-based study (CONCORD),” The Lancet Oncology, vol. 9, no. 8, pp. 730–756, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. Cancer Registry Annual Report, Department of Health, Executive Yuan, Taiwan, 2009.
  3. S. De Dosso, C. Sessa, and P. Saletti, “Adjuvant therapy for colon cancer: present and perspectives,” Cancer Treatment Reviews, vol. 35, no. 2, pp. 160–166, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Kopetz, D. Freitas, A. F. C. Calabrich, and P. M. Hoff, “Adjuvant chemotherapy for stage II colon cancer,” Oncology, vol. 22, no. 3, pp. 260–270, 2008. View at Google Scholar · View at Scopus
  5. E. Ernst and B. R. Cassileth, “The prevalence of complementary/alternative medicine in cancer: a systematic review,” Cancer, vol. 83, pp. 777–782, 1998. View at Google Scholar
  6. R. E. Patterson, M. L. Neuhouser, M. M. Hedderson et al., “Types of alternative medicine used by patients with breast, colon, or prostate cancer: predictors, motives, and costs,” Journal of Alternative and Complementary Medicine, vol. 8, no. 4, pp. 477–485, 2002. View at Google Scholar · View at Scopus
  7. M. A. Richardson, T. Sanders, J. L. Palmer, A. Greisinger, and S. E. Singletary, “Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology,” Journal of Clinical Oncology, vol. 18, no. 13, pp. 2505–2514, 2000. View at Google Scholar · View at Scopus
  8. L. An, J. Tang, X. Liu, and N. Gao, “Review about mechanisms of anti-cancer of Solanum nigrum,” Zhongguo Zhongyao Zazhi, vol. 31, no. 15, pp. 1225–1260, 2006. View at Google Scholar · View at Scopus
  9. S. L. McCarthy, R. J. Hinde, K. J. Miller, J. S. Anderson, H. Basch, and M. Krauss, “Theoretical studies of cis-Pt(II)-diammine binding to duplex DNA,” Biopolymers, vol. 29, no. 4-5, pp. 823–836, 1990. View at Google Scholar · View at Scopus
  10. V. Ganansia-Leymarie, P. Bischoff, J. Bergerat, and V. Holl, “Signal transduction pathways of taxanes-induced apoptosis,” Current Medicinal Chemistry, vol. 3, no. 4, pp. 291–306, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Zhang, T. Zhang, Y. Qu et al., “Replication-dependent γ-H2AX formation is involved in docetaxel-induced apoptosis in NSCLC A549 cells,” Oncology Reports, vol. 24, no. 5, pp. 1297–1305, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. R. A. Forrest, L. P. Swift, A. Rephaeli et al., “Activation of DNA damage response pathways as a consequence of anthracycline-DNA adduct formation,” Biochemical Pharmacology, vol. 83, no. 12, pp. 1602–1612, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Cummings and J. F. Smyth, “DNA topoisomerase I and II as targets for rational design of new anticancer drugs,” Annals of Oncology, vol. 4, no. 7, pp. 533–543, 1993. View at Google Scholar · View at Scopus
  14. M. S. Mano and F. Duhoux, “Colon cancer: update on adjuvant therapy,” Clinical Colorectal Cancer, vol. 7, no. 3, pp. 178–183, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. A. de Gramont, A. De Gramont, B. Chibaudel, A. K. Larsen, C. Tournigand, and T. Andr, “The evolution of adjuvant therapy in the treatment of early-stage colon cancer,” Clinical Colorectal Cancer, vol. 10, no. 4, pp. 218–226, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Lombardi, F. Morelli, S. Cinieri et al., “Adjuvant colon cancer chemotherapy: where we are and where we'll go,” Cancer Treatment Reviews, vol. 36, supplement 3, pp. S34–S41, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. D. B. Longley, D. P. Harkin, and P. G. Johnston, “5-Fluorouracil: mechanisms of action and clinical strategies,” Nature Reviews Cancer, vol. 3, no. 5, pp. 330–338, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. W. Xu, A. D. Towers, P. Li, and J.-P. Collet, “Traditional Chinese medicine in cancer care: perspectives and experiences of patients and professionals in China,” European Journal of Cancer Care, vol. 15, no. 4, pp. 397–403, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. F. Qi, A. Li, Y. Inagaki et al., “Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer,” Bioscience Trends, vol. 4, no. 6, pp. 297–307, 2010. View at Google Scholar · View at Scopus
  20. M. Youns, J. D. Hoheisel, and T. Efferth, “Traditional Chinese Medicines (TCMs) for molecular targeted therapies of tumours,” Current Drug Discovery Technologies, vol. 7, no. 1, pp. 37–45, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Hu, H. Kobayashi, A. Dong, Y. Jing, S. Iwasaki, and X. Yao, “Antineoplastic agents III: steroidal glycosides from Solanum nigrum,” Planta Medica, vol. 65, no. 1, pp. 35–38, 1999. View at Google Scholar · View at Scopus
  22. H. C. Huang, K. Y. Syu, and J. K. Lin, “Chemical composition of Solanum nigrum linn extract and induction of autophagy by leaf water extract and its major flavonoids in AU565 breast cancer cells,” Journal of Agricultural and Food Chemistry, vol. 58, no. 15, pp. 8699–8708, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Shokrzadeh, M. Azadbakht, N. Ahangar, A. Hashemi, and S. S. Saeedi Saravi, “Cytotoxicity of hydro-alcoholic extracts of Cucurbita pepo and Solanum nigrum on HepG2 and CT26 cancer cell lines,” Pharmacognosy Magazine, vol. 6, no. 23, pp. 176–179, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. C. J. Tai, C. K. Wang, Y. J. Chang, and C. S. Lin, “Aqueous extract of Solanum nigrum leaf activates autophagic cell death and enhances docetaxel-induced cytotoxicity in human endometrial carcinoma cells,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 859185, 10 pages, 2012. View at Publisher · View at Google Scholar
  25. H. M. Lin, H. C. Tseng, C. J. Wang et al., “Induction of autophagy and apoptosis by the extract of Solanum nigrum Linn in HepG2 cells,” Journal of Agricultural and Food Chemistry, vol. 55, no. 9, pp. 3620–3628, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. I. Tanida, T. Ueno, and E. Kominami, “LC3 and autophagy,” Methods in Molecular Biology, vol. 445, pp. 77–88, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. T. C. Chou, “Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies,” Pharmacological Reviews, vol. 58, no. 3, pp. 621–681, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Petiot, E. Ogier-Denis, E. F. C. Blommaart, A. J. Meijer, and P. Codogno, “Distinct classes of phosphatidylinositol 3'-kinases are involved in signaling pathways that control macro-autophagy in HT-29 cells,” Journal of Biological Chemistry, vol. 275, no. 16, pp. 992–998, 2000. View at Google Scholar · View at Scopus
  29. A. Yamamoto, Y. Tagawa, T. Yoshimori, Y. Moriyama, R. Masaki, and Y. Tashiro, “Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells,” Cell Structure and Function, vol. 23, no. 1, pp. 33–42, 1998. View at Google Scholar · View at Scopus
  30. I. Tanida, N. Minematsu-Ikeguchi, T. Ueno, and E. Kominami, “Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy,” Autophagy, vol. 1, no. 2, pp. 84–91, 2005. View at Google Scholar · View at Scopus
  31. E. White, “Deconvoluting the context-dependent role for autophagy in cancer,” Nature Reviews Cancer, vol. 12, pp. 401–410, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. A. M. Choi, S. W. Ryter, and B. Levine, “Autophagy in human health and disease,” The New England Journal of Medicine, vol. 368, pp. 1845–1846, 2013. View at Google Scholar
  33. J. Li, N. Hou, A. Faried, S. Tsutsumi, and H. Kuwano, “Inhibition of autophagy augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in vivo model,” European Journal of Cancer, vol. 46, no. 10, pp. 1900–1909, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. D. Chendil, R. Oakes, R. A. Alcock et al., “Low dose fractionated radiation enhances the radiosensitization effect of paclitaxel in colorectal tumor cells with mutant p53,” Cancer, vol. 89, pp. 1893–1900, 2000. View at Google Scholar
  35. D. Rajesh, K. Schell, and A. K. Verma, “Ras mutation, irrespective of cell type and p53 status, determines a cell's destiny to undergo apoptosis by okadaic acid, an inhibitor of protein phosphatase 1 and 2A,” Molecular Pharmacology, vol. 56, no. 3, pp. 515–525, 1999. View at Google Scholar · View at Scopus
  36. S. J. Lee, J. H. Ko, and K. T. Lim, “Glycine- and proline-rich glycoprotein isolated from Solanum nigrum Linne activates caspase-3 through cytochrome c in HT-29 cells.,” Oncology reports, vol. 14, no. 3, pp. 789–796, 2005. View at Google Scholar · View at Scopus
  37. Y. B. Ji, S. Y. Gao, C. F. Ji, and X. Zou, “Induction of apoptosis in HepG2 cells by solanine and Bcl-2 protein,” Journal of Ethnopharmacology, vol. 115, no. 2, pp. 194–202, 2008. View at Publisher · View at Google Scholar · View at Scopus
  38. P. S. Oh and K. T. Lim, “HeLa cells treated with phytoglycoprotein (150 kDa) were killed by activation of caspase 3 via inhibitory activities of NF-κB and AP-1,” Journal of Biomedical Science, vol. 14, no. 2, pp. 223–232, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. Y.-O. Son, J. Kim, J.-C. Lim, Y. Chung, G.-H. Chung, and J.-C. Lee, “Ripe fruits of Solanum nigrum L. inhibits cell growth and induces apoptosis in MCF-7 cells,” Food and Chemical Toxicology, vol. 41, no. 10, pp. 1421–1428, 2003. View at Publisher · View at Google Scholar · View at Scopus